Scholars Central

Research articlePublished 22 Jan 2013

Prevention of Cervical Cancer in Women: Human Papillomavirus DNA Testing in Atypical Pap Smears

Authors: Massimo Origoni, Guia Carminati, Chiara Gelardi, Francesca Occhi, Chiara Stefani

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Human papillomavirus (HPV) is definitely recognized as the necessary cause for the development of cancer of the uterine cervix and the detection of HPV-DNA in cervical samples is demonstrated to own a significantly higher sensitivity towards preneoplastic lesions than conventional cytology (Pap test). Screening, management of atypical Pap tests and follow up of treated patients, represent the optimal settings where HPV-DNA testing has been demonstrated of clinical value. Atypical Pap tests account for cases in which the cytological alterations cannot clearly be attributed neither to negative nor to positive cytology; in these cases HPV-DNA testing has been demonstrated to have a sensitivity very close to 100% in identifying patients with an histologically proven intraepithelial preneoplastic lesion of high grade (CIN2-CIN3).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Virology & Antiviral Research
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Massimo Origoni”
  • BylineArticles whose byline prints “Guia Carminati”
  • BylineArticles whose byline prints “Chiara Gelardi”
  • BylineArticles whose byline prints “Francesca Occhi”
  • BylineArticles whose byline prints “Chiara Stefani”